Literature DB >> 1709070

Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study.

H Tamai1, S Matsuo, A Fukatsu, K Nishikawa, N Sakamoto, K Yoshioka, N Okada, H Okada.   

Abstract

The 20-kD homologous restriction factor (HRF20), which is identical to CD59, is a membrane-associated protein which inhibits the reaction of C9 to form membrane attack complex (MAC) of homologous complements. In various human glomerular diseases deposition of complement components is frequently seen and MAC is reported to associate with immune deposits. Using a specific monoclonal antibody, 1F5, against HRF20, we attempted to study the localization of HRF20 in human glomerulonephritides and to compare the localization of HRF20 with those of immune deposits and MAC. The frozen sections of kidney specimens were fixed in acetone at room temperature before staining. In normal kidneys and kidney specimens from the patients with minimal change nephrotic syndrome, membranous nephropathy, and IgA nephropathy, HRF20 was strongly localized in the peritubular capillaries and along Bowman's capsules. A weaker but well-defined staining was obtained in the mesangial area and faint staining was seen along the glomerular capillary walls. In contrast, glomerular capillary walls were rather strongly stained in the cases with diffuse lupus nephritis which had subendothelial dense deposits. These data suggest that HRF20 (CD59) is present in the human glomeruli and its expression is enhanced under certain conditions such as lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709070      PMCID: PMC1535408          DOI: 10.1111/j.1365-2249.1991.tb08158.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Isolation from human erythrocytes of a new membrane protein which inhibits the formation of complement transmembrane channels.

Authors:  Y Sugita; Y Nakano; M Tomita
Journal:  J Biochem       Date:  1988-10       Impact factor: 3.387

Review 2.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

3.  Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action.

Authors:  E M Hoffmann
Journal:  Immunochemistry       Date:  1969-05

4.  20 KDa homologous restriction factor of complement resembles T cell activating protein.

Authors:  H Okada; Y Nagami; K Takahashi; N Okada; T Hideshima; H Takizawa; J Kondo
Journal:  Biochem Biophys Res Commun       Date:  1989-08-15       Impact factor: 3.575

5.  Localization of decay accelerating factor in normal and diseased kidneys.

Authors:  F G Cosio; D D Sedmak; J D Mahan; N S Nahman
Journal:  Kidney Int       Date:  1989-07       Impact factor: 10.612

6.  Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

7.  Membrane attack complex deposition in experimental glomerular injury.

Authors:  D T Perkinson; P J Baker; W G Couser; R J Johnson; S Adler
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

8.  Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.

Authors:  R J Falk; E Podack; A P Dalmasso; J C Jennette
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

9.  A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

10.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  12 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  Dynamic control of the complement system by modulated expression of regulatory proteins.

Authors:  Joshua M Thurman; Brandon Renner
Journal:  Lab Invest       Date:  2010-10-04       Impact factor: 5.662

Review 3.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.

Authors:  Brandon Renner; Kathrin Coleman; Ryan Goldberg; Claudia Amura; Amanda Holland-Neidermyer; Kathryn Pierce; Heather N Orth; Hector Molina; Viviana P Ferreira; Claudio Cortes; Michael K Pangburn; V Michael Holers; Joshua M Thurman
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

Review 5.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

6.  Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Authors:  L Cheng; S-J Gou; H-Y Qiu; L Ma; P Fu
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

7.  Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

Authors:  M Endoh; M Yamashina; H Ohi; K Funahashi; T Ikuno; T Yasugi; J P Atkinson; H Okada
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

8.  Activated C3 (C3b) in the nephritic glomerulus.

Authors:  C Pan; C F Strife; A J McAdams; C D West
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Tissue distribution of complement regulatory membrane proteins in rats.

Authors:  K Funabashi; N Okada; S Matsuo; T Yamamoto; B P Morgan; H Okada
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  Activation of intrarenal complement system in mouse model for chronic cyclosporine nephrotoxicity.

Authors:  Young Ok Kim; Sun Woo Lim; Can Li; Hee Jung Kang; Kyung Ohk Ahn; Hyun Joo Yang; Jung Yeon Ghee; Su Hyun Kim; Jin Young Kim; Bum Soon Choi; Jin Kim; Chul Woo Yang
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.